| AASLD | American Association for the Study of Liver Disease |
| AFP | alpha-fetoprotein |
| ALD | alcoholic liver disease |
| ALT | alanine aminotransferase |
| APOB | apolipoprotein B |
| AST | aspartate aminotransferase |
| AUROC | area under receiver operating characteristic curve |
| BMI | body mass index |
| CAP | controlled attenuation parameter |
| CCRK | cycle-related kinase |
| ctDNAs | cell-circulating tumor DNAs |
| CLD | chronic liver disease |
| CEUS | contrast-enhanced ultrasound |
| Circ-RNAs | circular non-coding RNAs |
| CT | computed tomography |
| DAAs | direct antiviral agents |
| DCP | des-gamma carboxyprothrombin |
| DPP4 | dipeptidyl peptidase 4 |
| EASL | European Association for the Study of the Liver |
| ECM | extracellular matrix |
| ELF | enhanced liver fibrosis |
| ER | endoplasmic reticulum |
| FFAs | free fatty acids |
| FIB-4 | fibrosis-4 index |
| GCKR | glucokinase regulator |
| GP73 | Golgi protein-73 |
| GPC3 | glypican-3 |
| GPCRs | G protein-coupled receptors |
| HA | hyaluronic acid |
| HBV | hepatitis B virus |
| HCC | hepatocellular carcinoma |
| HCV | hepatitis C virus |
| HIF1α | hypoxia-inducible factor-1a |
| HIV | human immunodeficiency virus |
| HR | hazard ratio |
| HSCs | hepatic stellate cells |
| HSD17B13 | 17beta-hydroxysteroid dehydrogenase type 13 |
| ICB | immune checkpoint blockade |
| IFG | impaired fasting glucose |
| IFN-γ | interferon-gamma |
| IL | interleukin |
| IR | insulin resistance |
| Li-RADS | Liver Imaging Reporting and Data System |
| lncRNAs | long non-coding RNAs |
| LSM | liver stiffness measurement |
| MBOAT7 | membrane-bound O-acyltransferase domain-containing 7 |
| miRNA | microRNA |
| MRE | miRNA response elements |
| MRI | magnetic resonance imaging |
| MTA1 | metastasis-associated protein 1 |
| NAFLD | non-alcoholic fatty liver disease |
| NASH | non-alcoholic fatty liver disease |
| ncRNAs | non-coding RNAs |
| NFS | NAFLD fibrosis score |
| NITs | non-invasive tests |
| NLR | neutrophil-lymphocyte ratio |
| NTS | neurotensin |
| OPN | osteopontin |
| PD-1 | programmed cell death-1 |
| PDC1 | programmed cell death 1 |
| PDL | programmed death ligand |
| PIVKA II | pro-thrombin induced by vitamin K absence-II |
| PLT | platelets |
| PNPLA3 | patatin-like phospholipase domain-containing 3 |
| PRS | polygenic risk score |
| PSRC1 | proline/serine-rich coiled-coil protein 1 |
| P3NP | pro-peptide of type 3 procollagen |
| RCT | randomized clinical trial |
| ROS | reactive oxygen species |
| SGLT2 | sodium-glucose cotransporter-2 |
| SNP | single-nucleotide polymorphisms |
| SVR | sustained virological response |
| TE | transient elastography |
| TERT | telomerase reverse transcriptase |
| TIMP1 | tissue inhibitor of matrix metalloproteinase type 1 |
| TM6SF2 | transmembrane 6 superfamily member 2 |
| T2DM | type 2 diabetes mellitus |
| TNFs | tumor necrosis factor superfamily |
| Tregs | T regulatory |
| US | ultrasound |
| VCTE | vibration-controlled transient elastography |
| VEGF | vascular endothelial growth factor |